Humana defends US antitrust claims against Merck over Zetia
MLex Summary: Humana opposed Merck’s motion to dismiss amended US claims accusing it of entering into an illegal pay-for-delay agreement, which kept a generic version of the cholesterol drug Zetia out...To view the full article, register now.
Already a subscriber? Click here to view full article